AstraZeneca, Daiichi Sankyo in $6B oncology deal – MarketWatch
Business News
- AstraZeneca, Daiichi Sankyo in $6B oncology deal MarketWatch
- AstraZeneca signs $6 billion cancer drug deal with Daiichi Reuters
- AstraZeneca to pay up to $6bn in cancer pact with Daiichi Sankyo Financial Times
- Astrazeneca secures $6bn cancer drug deal with Japan’s Daiichi City A.M.
- AstraZeneca bets up to $6 billion on new Daiichi cancer drug Reuters
- View Full Coverage on Google News
Source: Business News